| [1] |
葛均波. 内科学[M].9版．北京：人民卫生出版社，2018: 598-599.
|
| [2] |
Moulard O, Mehta J, Fryzek J, et al. Epidemiology of myelofibrosis, essential thrombocythemia, and polycythemia vera in the European Union[J]. Eur J Haematol, 2014, 92(4): 289-297.
|
| [3] |
蓝海峰，方志鸿，张悦，等. 438例原发性血小板增多症的临床分析[J]. 中华血液学杂志，2008(9)：587-591.
|
| [4] |
刘一霖，郭涛. 骨髓增殖性肿瘤血栓并发症的研究进展[J]. 临床内科杂志，2020，37(1)：8-11.
|
| [5] |
肖志坚. 原发性血小板增多症诊断与治疗中国专家共识(2016年版)[J]．中华血液学杂志，2016，37(10)：833-836.
|
| [6] |
Passamonti F, Randi M L, Rumi E, et al. Increased risk of pregnancy complications in patients with essential thrombocythemia carrying the JAK2 (617V>；F) mutation[J]. Blood, 2007，110(2)：485-489.
|
| [7] |
Melillo L, Tieghi A, Candoni A, et al. Outcome of 122 pregnancies in essential thrombocythemia patients: A report from the Italian registry[J]. Am J Hematol, 2009, 84(10)：636-640.
|
| [8] |
周莉，范玲．妊娠期凝血功能特点[J/CD]．中华产科急救电子杂志，2014，3(2)：81-85.
|
| [9] |
Wright CA, Tefferi A. A single institutional experience with 43 pregnancies in essential thrombocythemia[J]. Eur J Haematol, 2001，66(3)：152-159.
|
| [10] |
董阳阳，梁梅英. 妊娠合并原发性血小板增多症的诊治[J]. 中华妇产科杂志，2016，51(3)：233-237.
|
| [11] |
Maze D, Kazi S, Gupta V, et al. Association of treatments for myeloproliferative neoplasms during pregnancy with birth rates and maternal outcomes: a systematic review and meta-analysis[J]．JAMA Netw Open, 2019，2(10): e1912666.
|
| [12] |
Skeith L, Carrier M, Robinson SE, et al. Risk of venous thromboembolism in pregnant women with essential thrombocythemia: a systematic review and meta-analysis[J]. Blood, 2017，129(8)：934-939.
|
| [13] |
夏云金，周梅玲，万楚成，等. 治疗性血小板单采术在血小板增多症患者中的应用[J]．血栓与止血学，2011，17(6): 266-268.
|